Barclays’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-97,200
| Closed | -$7.47M | – | 5111 |
|
|
2022
Q4 | $7.47M | Buy |
+97,200
| New | +$7.39M | ﹤0.01% | 1366 |
|
|
2021
Q1 | – | Sell |
-24,000
| Closed | -$1.28M | – | 4724 |
|
|
2020
Q4 | $1.28M | Hold |
24,000
| – | – | ﹤0.01% | 2584 |
|
|
2020
Q3 | $1.13M | Sell |
24,000
-1,800
| -7% | -$92.4K | ﹤0.01% | 2587 |
|
|
2020
Q2 | $1.35M | Sell |
25,800
-105,900
| -80% | -$5.46M | ﹤0.01% | 2485 |
|
|
2020
Q1 | $6.31M | Buy |
131,700
+51,300
| +64% | +$2.66M | 0.01% | 1288 |
|
|
2019
Q4 | $4.07M | Buy |
80,400
+24,000
| +43% | +$1.24M | ﹤0.01% | 2236 |
|
|
2019
Q3 | $2.66M | Sell |
56,400
-41,700
| -43% | -$1.9M | ﹤0.01% | 2513 |
|
|
2019
Q2 | $4.62M | Buy |
98,100
+46,000
| +88% | +$2.12M | ﹤0.01% | 1928 |
|
|
2019
Q1 | $2.51M | Sell |
52,100
-41,600
| -44% | -$2.08M | ﹤0.01% | 2332 |
|
|
2018
Q4 | $4.18M | Buy |
93,700
+34,600
| +59% | +$1.8M | ﹤0.01% | 1718 |
|
|
2018
Q3 | $3.19M | Sell |
59,100
-20,800
| -26% | -$1.06M | ﹤0.01% | 2328 |
|
|
2018
Q2 | $3.9M | Buy |
79,900
+12,600
| +19% | +$714K | ﹤0.01% | 1934 |
|
|
2018
Q1 | $4.22M | Sell |
67,300
-23,800
| -26% | -$1.63M | ﹤0.01% | 1779 |
|
|
2017
Q4 | $5.58M | Buy |
91,100
+83,700
| +1,131% | +$5.17M | ﹤0.01% | 1590 |
|
|
2017
Q3 | $495K | Sell |
7,400
-6,500
| -47% | -$459K | ﹤0.01% | 3637 |
|
|
2017
Q2 | $1.08M | Buy |
13,900
+12,900
| +1,290% | +$974K | ﹤0.01% | 2810 |
|
|
2017
Q1 | $82K | Sell |
1,000
-6,300
| -86% | -$496K | ﹤0.01% | 5026 |
|
|
2016
Q4 | $525K | Sell |
7,300
-13,200
| -64% | -$954K | ﹤0.01% | 3318 |
|
|
2016
Q3 | $1.59M | Buy |
20,500
+16,900
| +469% | +$1.37M | ﹤0.01% | 2185 |
|
|
2016
Q2 | $281K | Buy |
3,600
+1,000
| +38% | +$79.7K | ﹤0.01% | 3674 |
|
|
2016
Q1 | $211K | Sell |
2,600
-600
| -19% | -$48.8K | ﹤0.01% | 3809 |
|
|
2015
Q4 | $285K | Sell |
3,200
-2,500
| -44% | -$212K | ﹤0.01% | 3623 |
|
|
2015
Q3 | $433K | Sell |
5,700
-5,400
| -49% | -$451K | ﹤0.01% | 3484 |
|
|
2015
Q2 | $921K | Buy |
11,100
+5,400
| +95% | +$477K | ﹤0.01% | 2951 |
|
|
2015
Q1 | $513K | Sell |
5,700
-107,600
| -95% | -$9.26M | ﹤0.01% | 3594 |
|
|
2014
Q4 | $9.06M | Buy |
113,300
+86,700
| +326% | +$6.85M | 0.01% | 1253 |
|
|
2014
Q3 | $1.97M | Buy |
26,600
+7,300
| +38% | +$531K | ﹤0.01% | 2680 |
|
|
2014
Q2 | $1.31M | Buy |
19,300
+6,500
| +51% | +$443K | ﹤0.01% | 3062 |
|
|
2014
Q1 | $884K | Sell |
12,800
-130,800
| -91% | -$9.1M | ﹤0.01% | 3364 |
|
|
2013
Q4 | $9.48M | Buy |
143,600
+102,200
| +247% | +$6.25M | 0.01% | 1290 |
|
|
2013
Q3 | $2.15M | Sell |
41,400
-46,900
| -53% | -$2.38M | ﹤0.01% | 2479 |
|
|
2013
Q2 | $4.17M | Buy |
+88,300
| New | +$4.03M | 0.01% | 1777 |
|
Other funds holding CAH
VCM
VPM
Barclays's CAH Position: Q1 2026 in Review
Barclays reduced its Cardinal Health (CAH) stake by 18% in Q1 2026, selling an estimated $46.2M and leaving 993,914 shares worth $210M. The position accounts for 0.05% of the portfolio, ranked #288.
Barclays first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $249M in Q3 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Barclays held 993,914 shares of Cardinal Health worth $210M as of Q1 2026.
- Barclays sold 214,685 Cardinal Health shares in Q1 2026, an estimated $46.2M.
- Cardinal Health made up 0.05% of Barclays's portfolio in Q1 2026, its #288 holding.
- Barclays first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
- Barclays's Cardinal Health position peaked at $249M in Q3 2025.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.